AI量化CAC CT肌肉衰减预测房颤与心衰
基于多种族动脉粥样硬化研究5739名无基线心血管病参与者,回顾性分析CAC扫描中AI量化的胸廓骨骼肌平均衰减。肌脂肪变性独立预测总CVD、房颤和心衰,加入Agatston评分后显著提升预测效能。
要点
- CAC扫描上AI量化的胸廓骨骼肌平均衰减可识别肌脂肪变性,无需额外扫描
- 肌脂肪变性合并高Agatston评分者房颤、心衰累积发生率明显更高
- 报告中可关注骨骼肌衰减作为心血管事件风险的附加信息
核心结论
- AI量化的CAC扫描胸廓骨骼肌平均衰减独立预测房颤和心衰,并增强Agatston评分的预测价值
研究设计与样本
- 回顾性分析多种族动脉粥样硬化研究数据,纳入5739名无基线CVD且接受CAC扫描的参与者,平均年龄62.1岁±10.3,女性3002名占52.3%
- 肌脂肪变性由性别特异性AI量化平均胸廓骨骼肌衰减截断值定义,随访19年共1826例CVD事件,其中房颤1139例、心衰359例
关键影像表现/征象
- CAC CT上可见胸廓骨骼肌平均衰减减低,符合肌脂肪变性的影像表现
诊断标准与关键数值
- 肌脂肪变性独立关联总CVD风险HR为1.48(95%CI:1.25,1.75;P=.001)
- 肌脂肪变性独立关联房颤风险HR为1.68(95%CI:1.37,2.07;P<.001)
- 肌脂肪变性独立关联心衰风险HR为1.61(95%CI:1.18,2.19;P<.002)
- 肌脂肪变性合并高Agatston评分者总CVD累积发生率为84.6%,高于仅高Agatston评分者的68.6%
- 肌脂肪变性合并高Agatston评分者房颤累积发生率为52.9%,高于仅高Agatston评分者的42.4%
临床应用与阅片要点
- 日常阅片CAC扫描时可同时评估胸廓骨骼肌衰减,无需额外影像检查
- 骨骼肌低衰减者即使Agatston评分不高也需关注房颤和心衰风险
局限性
- 回顾性分析设计
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate whether the artificial intelligence (AI)-quantified mean thoracic skeletal muscle (TSM) attenuation from coronary artery calcium (CAC) scans predicts incident cardiovascular disease (CVD), with a focus on atrial fibrillation (AF) and heart failure (HF). Materials and Methods Data from the Multi-Ethnic Study of Atherosclerosis, including participants without baseline CVD who underwent CAC scanning, were retrospectively analyzed. Myosteatosis was defined by sex-specific, AI-quantified mean TSM attenuation cutoffs. The Cox proportional hazards model was used to compare total CVD, AF, and HF risks between the bottom and top quartiles of TSM attenuation after adjusting for CVD risk factors, inflammatory markers, insulin resistance, Agatston score, TSM volume, and social determinants of health. Results Among 5739 participants (mean age, 62.1 years ± 10.3 [SD]; 3002 [52.3%] female), 1826 CVD events occurred over 19 years, including 1139 AF and 359 HF events. Myosteatosis was independently associated with increased risks of total CVD (hazard ratio [HR], 1.48 [95% CI: 1.25, 1.75]; P = .001), AF (HR, 1.68 [95% CI: 1.37, 2.07]; P < .001), and HF (HR, 1.61 [95% CI: 1.18, 2.19]; P < .002). Participants with both myosteatosis and high Agatston scores had markedly higher cumulative incidences compared with those with high Agatston scores alone (total CVD: 84.6% vs 68.6%; AF: 52.9% vs 42.4%; HF: 22.6% vs 16.1%). Adding myosteatosis to the Agatston score significantly improved prediction (time-dependent area under the receiver operating characteristic curve, total CVD: 0.74 vs 0.80, P < .001; AF: 0.68 vs 0.76, P < .001; HF: 0.73 vs 0.78, P = .007). Conclusion AI-quantified mean TSM attenuation on CAC scans independently predicted AF and HF and enhanced the Agatston score's predictive value. Keywords: Myosteatosis, Coronary Artery Calcium Scan, Atrial Fibrillation, Heart Failure, Artificial Intelligence, Applications-CT, Cardiac, Thorax, Muscular, Heart ClinicalTrials.gov NCT00005487 Supplemental material is available for this article. © RSNA, 2026.
引用
- Azimi, Atlas, Reeves, et al. AI-quantified Myosteatosis at CAC CT for Prediction of Atrial Fibrillation and Heart Failure: The Multi-Ethnic Study of Atherosclerosis. Radiol Cardiothorac Imaging. 2026. PMID: 42390348. doi:10.1148/ryct.250214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。